Xenetic Biosciences, Inc.
XBIO
$3.28
$0.196.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.00% | 18.11% | 67.21% | -18.79% | 16.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.00% | 18.11% | 67.21% | -18.79% | 16.15% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 36.00% | 18.11% | 67.21% | -18.79% | 16.15% |
| SG&A Expenses | -1.37% | -12.72% | 9.32% | -41.79% | -21.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.76% | -20.52% | 41.12% | -36.32% | -13.69% |
| Operating Income | 46.72% | 43.32% | -9.05% | 45.84% | 25.70% |
| Income Before Tax | 49.46% | 45.08% | -16.76% | 45.94% | 24.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 49.46% | 45.08% | -16.76% | 45.94% | 24.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.46% | 45.08% | -16.76% | 45.94% | 24.43% |
| EBIT | 46.72% | 43.32% | -9.05% | 45.84% | 25.70% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 65.98% | 61.16% | -16.77% | 45.98% | 24.51% |
| Normalized Basic EPS | 65.98% | 61.16% | -16.78% | 45.99% | 24.50% |
| EPS Diluted | 65.98% | 61.16% | -16.77% | 45.98% | 24.51% |
| Normalized Diluted EPS | 65.98% | 61.16% | -16.78% | 45.99% | 24.50% |
| Average Basic Shares Outstanding | 48.57% | 41.36% | 0.03% | 0.08% | 0.09% |
| Average Diluted Shares Outstanding | 48.57% | 41.36% | 0.03% | 0.08% | 0.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |